Precise Software Solutions Inc. (Precise) is pleased to announce its award to support the U.S. Food and Drug Administration (FDA) in developing a Conversational AI Strategy.
As part of the project, Precise will develop a proof-of-concept that includes both a chatbot and smart speaker application powered by content from FDA.gov. This solution aims to demonstrate how conversational AI platforms can simplify and improve access to public health information.
The project also includes designing the dialog flow and mapping user intentions to key content areas. These flows will be enhanced with integrated search capabilities to help users find relevant information, even when direct matches are unavailable.
“Our work with the FDA reflects our deep commitment to advancing public-facing technology that is accessible, intuitive, and mission-driven,” said Zhensen Huang, CEO of Precise. “Conversational AI has the potential to transform how citizens interact with government services, and we’re honored to help the FDA lead the way in this innovation.”
In future phases, Precise will support the development and implementation of AI-powered chatbot solutions to enhance the user experience across FDA.gov.
